Related Experiment Videos

Perphenazine decreases vomiting by children after tonsillectomy

W M Splinter1, D J Roberts

  • 1Department of Anaesthesia, Children's Hospital of Eastern Ontario, Ottawa, Canada. Splinter@cheo.on.ca

Insights

Perphenazine effectively reduces post-tonsillectomy vomiting in children. This study found fewer vomiting episodes and less need for rescue antiemetics in children receiving perphenazine compared to placebo.

Area of Science:

  • Pediatric Anesthesiology
  • Pharmacology
  • Surgical Outcomes

Background:

  • Post-tonsillectomy nausea and vomiting (PONV) is a common complication in pediatric patients.
  • Effective antiemetic prophylaxis is crucial for improving patient recovery and reducing hospital stay.

Purpose of the Study:

  • To evaluate the efficacy of perphenazine in preventing vomiting in children following tonsillectomy.
  • To test the hypothesis that perphenazine administration decreases the incidence of post-tonsillectomy emesis.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial involving 260 children aged 2-12 years undergoing tonsillectomy.
  • Participants received either intravenous perphenazine (70 µg/kg, max 5 mg) or placebo before surgery.
  • Standardized management of fluids, emesis, and pain was implemented.

Main Results:

  • Perphenazine significantly reduced vomiting incidence within 24 hours post-surgery (42% vs. 57% in placebo group, P < 0.01).
  • Fewer rescue antiemetics were required in the perphenazine group (P < 0.05).
  • Each vomiting episode delayed hospital discharge by approximately 20 minutes.

Conclusions:

  • Prophylactic perphenazine is effective in decreasing vomiting in children after tonsillectomy.
  • Perphenazine improves outcomes by reducing emesis and potentially shortening hospital stays.
Abstract

Related Concept Videos